StockClub

BCRX

BCRXBioCryst Pharmaceuticals, Inc.$ --
BioCryst Pharmaceuticals, Inc.

BioCryst Pharmaceuticals, Inc.

BCRX

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 12/31/2025FY2025 Q4
Revenue
407M USD
YoY +209.1%
Operating Income
260M USD
YoY +5876.1%
Net Income
246M USD
YoY +1017.5%
EPS
1.17$
YoY +1000.0%

Revenue

$874.8M
FY2024 Q1$92.8M
$92.8M
Q1
FY2024 Q2$202.1M
$202.1M
Q2
FY2024 Q3$319.2M
$319.2M
Q3
FY2024 Q4$450.7M
$450.7M
Q4
FY2025 Q1$145.5M
$145.5M
Q1
FY2025 Q2$308.9M
$308.9M
Q2
FY2025 Q3$468.3M
$468.3M
Q3
FY2025 Q4$874.8M
$874.8M
Q4
Actual
+$424.1M (+94.1%)

Net Income

$263.9M
FY2024 Q1$-35.4M
$-35.4M
Q1
FY2024 Q2$-48.1M
$-48.1M
Q2
FY2024 Q3$-62.1M
$-62.1M
Q3
FY2024 Q4$-88.9M
$-88.9M
Q4
FY2025 Q1$32,000
$32,000
Q1
FY2025 Q2$5.1M
$5.1M
Q2
FY2025 Q3$18M
$18M
Q3
FY2025 Q4$263.9M
$263.9M
Q4
Actual
+$352.7M (+396.9%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020MISS
Actual:$17.8M
Est:$28.6M
FY2020MISS
$17.8M
FY2021MISS
Actual:$157.2M
Est:$160.4M
FY2021MISS
$157.2M
FY2022BEAT
Actual:$270.8M
Est:$265.4M
FY2022BEAT
$270.8M
FY2023MISS
Actual:$331.4M
Est:$382.2M
FY2023MISS
$331.4M
FY2024BEAT
Actual:$450.7M
Est:$449.3M
FY2024BEAT
$450.7M
FY2025BEAT
Actual:$874.8M
Est:$619.5M
FY2025BEAT
$874.8M

Analyst Estimates